Company news
Cambium Bio Ltd news in 2018
Cambium Bio Ltd's news releases, calls and decks from 2018, newest first.
Chinese patent granted for biomarkers for stem cell therapy
December 2, 2018
Re-Released - Appendix 4C - Quarterly
October 23, 2018
Progenza patent to grant in Europe
October 17, 2018
Regeneus receives R&D tax incentive refund of $2.4m
September 5, 2018
Positive clinical trial results for cancer vaccine
July 30, 2018
US Patent Office to allow key patent for Progenza
July 9, 2018
Update on licensing Progenza in Japan
July 3, 2018
European Medicines Agency grants Progenza ATMP status
February 13, 2018
Japanese Patent Office to grant patent for cancer vaccine
February 11, 2018
Regeneus Announces Successful Results in Acne Study
February 6, 2018